(888) 440-0954


Please join us for a symposium on Genomics

Dr. Anup Madan
Vice President, Strategic Alliance, of TwinStrand Biosciences

Topic: One-in-A-Million: Applications of Duplex Sequencing
Dr. Anup Madan is a Vice President, Strategic Alliance, of TwinStrand Biosciences. His research interests lie in studying somatic evolution and the genomic processes that occur on the continuum between “normal”, preneoplastic and cancer, and applying this to knowledge to clinical medicine. TwinStrand Biosciences develops ultrasensitive Duplex Sequencing-based assays for early detection of cancer, residual disease monitoring and genotoxin assessment. Duplex Sequencing enables an unprecedented level of NGS accuracy, with error rates below one-in-ten-million. The technology is ideally suited to early detection of cancer, among other high sensitivity fields. Here we illustrate clinically-relevant case studies where such accuracy is critical.

Prior to joining TwinStrand Biosciences, Dr Madan was Executive Director at Covance and led a group that offered Genomics solution to various pharmaceutical companies for clinical trials. Some of the biomarkers identified by his group are being developed as companion/complementary diagnostics for various oncology drugs. He continues to collaborate with both academic and pharmaceutical groups and had published in various well reputed journals.

Dr. Joseph Pickrell
CEO, Gencove

Topic: Low-pass sequencing for cost-effective and scalable genomics applications
Joe is a statistical geneticist who has published scientific papers in the most selective scientific journals like Nature, Science, Nature Genetics, and PNAS. Prior to founding Gencove, he was a professor at New York Genome Center and Columbia University, and he holds a PhD in Human Genetics from the University of Chicago.

05February2019 - 05February2019

6:00 pm to 9:00 pm PST

Foundry and Lux, 151 Oyster Point Blvd, South San Francisco, CA

AGBT provides a forum for exchanging information about the latest advances in DNA sequencing technologies, experimental and analytical approaches for genomic studies, and their myriad applications.

27February2019 - 02March2019

Marco Island, FL

The ASCO-SITC Clinical Immuno-Oncology Symposium is a three-day meeting focused on clinical and translational research in immuno-oncology and the implications for clinical care. This meeting will address the high-level of need for clinical education in a field where all aspects of care are fundamentally different from traditional therapies.

28February2019 - 02March2019

San Francisco, CA

The World Immunotherapy Congress brings together the pioneers doing the most innovative work within the industry and across the whole value chain, to share their unique insights with you.

The event looks at commercialising and pushing forward the entire developmental pipeline as well as focusing on the hottest new individual therapeutics.

Spanning five days, the 2019 Tri-Conference includes compelling talks, including case studies and joint partner presentations, will feature over 500 of your fellow industry and academic colleagues discussing themes of cancer research, big data, molecular diagnostics, precision medicine, rare diseases, data science, human microbiome, point-of-care diagnostics, infectious diseases, and so much more.

10March2019 - 15March2019

San Francisco, CA

Advancing ICI-containing IO-combination therapies is central to getting the full therapeutic benefit out of ICIs. Selecting the right combination partners and strategies are essential to the making the correct decision.

19March2019 - 21March2019

Boston, MA

The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.

29March2019 - 03April2019

Atlanta, Georgia, USA

The meeting place for vaccine professionals from industry, academia, non-profit organizations and government to discuss challenges and successes.

Cambridge Healthtech Institute’s Fifteenth Annual Biomarker World Congress is the longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. With the promising developments in immuno-oncology over the past five years, much of the biomarker R&D has shifted to discovery and development of predictive biomarkers for immunotherapy patient stratification, using biomarker or mechanism data to choose rational combination immunotherapy, and applying immune profiling to predict response to immunotherapy.

17June2019 - 20June2019

Boston, MA